Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome

Key facts

Sponsor

Johns Hopkins University

Principal Investigator

Marco A Grados, M.D., M.P.H.

Department of Psychiatry & Behavioral Sciences, Johns Hopkins School of Medicine

Intervention

N-acetyl cysteine(drug)

Enrollment

10 enrolled

Eligibility

13-35 years · All sexes

Timeline

2026 – 2027

Study locations (1)

• Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

Collaborators

Cornelia de Lange Syndrome Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Cornelia de Lange syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2, PHASE3NCT06789783
  Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment
  University of Milan
• RECRUITINGNANCT05829668
  Behavioral Assessment and Treatment of Problem Behavior in Children With Cornelia de Lange Syndrome
  Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

See all trials for Cornelia de Lange syndrome →